| 000 | 01296 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515112355.0 | ||
| 264 | 0 | _c20080422 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a0392-856X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBultink, I E M | |
| 245 | 0 | 0 |
_aPrevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus. _h[electronic resource] |
| 260 |
_bClinical and experimental rheumatology _c |
||
| 300 |
_a32-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aBlood Sedimentation |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xcomplications |
| 650 | 0 | 4 |
_aComplement C3 _xanalysis |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xepidemiology |
| 650 | 0 | 4 |
_aMethylprednisolone _xadverse effects |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aTurkstra, F | |
| 700 | 1 | _aDiamant, M | |
| 700 | 1 | _aDijkmans, B A C | |
| 700 | 1 | _aVoskuyl, A E | |
| 773 | 0 |
_tClinical and experimental rheumatology _gvol. 26 _gno. 1 _gp. 32-8 |
|
| 999 |
_c17830325 _d17830325 |
||